EU-7 criteria and its applicability in pharmacoepidemiological research in Central and Eastern Europe. 48th ESCP Symposium on Clinical Pharmacy "The Digital Revolution: Supporting clinical pharmacy through e-health, digital support systems, big data and more", Ljubljana, Slovenia, 23 - 25 October, 2019 (oral presentation ESCP19SY-1110, PE 001)

The EU-7 PIM (potentially inappropriate medication) criteria represents the most comprehensive and up-to-date tool for evaluation of PIM prescribing in Europe. In some EU countries, the lower availability of PIMs from EU-7 PIM list was confirmed which may decrease applicability of EU-7 criteria in clinical pharmacy (CP) research in these countries, however it might also decrease the use of PIMs. The aim of our study was to document approval rates, availability and prescription limits of EU-7 PIMs in several Central and Eastern European countries (CEECs) in order to describe the applicability of EU-7 tool and availability of PIMs when prescribing to older patients.oral presentation at the international conferenc